Columbia Laboratories Inc. (CBRX) Stock Quote
| Detailed Quote for Columbia Laboratories Inc. (CBRX) |
|
|
|
|
After Hours:
$ 0.78
|
-0.004 (-0.51%)
|
Volume: 2.65 k
|
6:48 PM EST Feb 10, 2012
|
|
|
|
close
52 Week Information
52 Week High
 April 6, 2011
Close:
4.31
52 Week Low
January 23, 2012
Close:
0.6421
|
|
|
|
|
| Change $ |
|---|
0.031
|
|
| Change % |
|---|
3.80%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
close
Exchange Information
Exchange |
|---|
NSD |
|
|
|
|
|
News and Media for Columbia Laboratories Inc.
(CBRX)
|
|
|
News for CBRX
|
|
|
|
| 11:00 AM |
Faruqi & Faruqi, LLP Announces Investigation of Columbia Laboratories Inc. - PR Newswire |
|
|
|
| 3:50 PM |
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Columbia Laboratories, Inc. - Business Wire |
|
|
|
| 2:57 PM |
The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Columbia Laboratories Inc. of Class Action Lawsuit and the Deadline of April 2, 2012 to Seek a Lead Plaintiff Position - Business Wire |
| 1:56 PM |
Robbins Umeda LLP Announces an Investigation of Columbia Laboratories, Inc. - Business Wire |
| 12:40 PM |
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Columbia Laboratories, Inc. (NASDAQ: CBRX) - Marketwire |
|
|
|
| 1:54 PM |
Holzer Holzer & Fistel, LLC Announces Investigation into Columbia Laboratories Inc. - Business Wire |
| 10:43 AM |
Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc. - Business Wire |
|
|
|
| 4:40 PM |
FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - PR Newswire |
|
|
|
| 2:54 PM |
The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by Columbia Laboratories Inc. - Business Wire |
|
|
|
| 6:59 AM |
Meta-analysis of Five Clinical Trials including Columbia Laboratories' PREGNANT Study Published in American Journal of Obstetrics and Gynecology - Business Wire |
|
|
|
| 10:00 PM |
Columbia Laboratories Will Present November 15th at Lazard Capital Markets Healthcare Conference - Business Wire |
|
|
|
| 9:48 AM |
Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA - PR Newswire |
|
|
|
| 9:05 AM |
Factors Moving Markets, Worldwide View - Equity Research on Columbia Laboratories Inc. and Accuray Incorporated - Marketwire |
|
More News for CBRX >> |
|
|
|
|
| Tags for Columbia Laboratories Inc. |
Research stocks or mutual funds related to Columbia Laboratories Inc. by keywords or tags.
Find companies that have a similar focus to CBRX. The keywords below have been
associated to CBRX by either user submission or electronic means.
biotechnology company
pharmaceutical market
Commercial Physical And Biological Research (8731)
pharmaceuticals companies
generic pharmaceutical
pharmaceutical investment
medical product development
biotechnology market
pharmaceutical research and development
drug delivery technologies
pharmaceutical manufacturing company
female fertility
pharma marketing
pharmaceutical industry marketing
pharmaceutical software
pharma manufacturing
pharma license
progesterone oil
low progesterone
generic products
progesterone cream
drug delivery
pharmaceutical cro
pharma companies
pharma consulting
clinical trials industry
drug delivery market
pharmaceutical distributors
pharmaceutical labs
pharmaceutical development
pharmaceutical reports
Drugs
pregnancy progesterone supplement
pharma r&d
infertility treatment
infertility
infertility causes
pharmaceutical manufacturing software
pharmaceutical manufacturing
pharmaceutical formulation
contract pharmaceutical
pharmaceutical consulting
pharmaceutical industry
crinone
pharmaceutical studies
pharmaceutical advances
pharmaceutical distributor
pharmaceutical out licensing
pharmaceutical business development
multinational pharmaceutical companies
